Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.06M Sell
7,480
-61
-0.8% -$17.2K 0.02% 214
2026
Q1
$2.01M Sell
7,541
-249
-3% -$68.9K 0.02% 199
2025
Q4
$2.14M Sell
7,790
-1,169
-13% -$328K 0.02% 193
2025
Q3
$2.58M Sell
8,959
-117
-1% -$34.6K 0.02% 162
2025
Q2
$3M Sell
9,076
-354
-4% -$114K 0.03% 144
2025
Q1
$3.1M Buy
9,430
+427
+5% +$129K 0.03% 143
2024
Q4
$2.49M Buy
9,003
+9
+0.1% +$2.87K 0.02% 163
2024
Q3
$3.12M Buy
8,994
+100
+1% +$34.4K 0.03% 141
2024
Q2
$2.94M Sell
8,894
-1,165
-12% -$402K 0.03% 137
2024
Q1
$3.65M Buy
10,059
+297
+3% +$97.8K 0.03% 115
2023
Q4
$2.92M Sell
9,762
-24
-0.2% -$7.01K 0.03% 129
2023
Q3
$2.8M Buy
9,786
+1,149
+13% +$328K 0.03% 124
2023
Q2
$2.42M Buy
8,637
+1,651
+24% +$430K 0.03% 142
2023
Q1
$1.79M Sell
6,986
-569
-8% -$166K 0.02% 176
2022
Q4
$2.5M Sell
7,555
-3,134
-29% -$992K 0.03% 138
2022
Q3
$2.97M Buy
10,689
+4,131
+63% +$1.16M 0.04% 116
2022
Q2
$1.73M Buy
6,558
+1,035
+19% +$267K 0.03% 150
2022
Q1
$1.32M Buy
5,523
+658
+14% +$154K 0.02% 196
2021
Q4
$1.12M Sell
4,865
-2,122
-30% -$451K 0.01% 225
2021
Q3
$1.4M Buy
6,987
+390
+6% +$84.8K 0.02% 173
2021
Q2
$1.56M Sell
6,597
-61
-0.9% -$15.2K 0.02% 160
2021
Q1
$1.61M Buy
6,658
+1,263
+23% +$282K 0.02% 140
2020
Q4
$1.12M Buy
5,395
+26
+0.5% +$5.1K 0.01% 168
2020
Q3
$910K Sell
5,369
-72
-1% -$12.7K 0.01% 175
2020
Q2
$1.02M Buy
5,441
+704
+15% +$134K 0.02% 152
2020
Q1
$839K Buy
4,737
+1,360
+40% +$264K 0.02% 151
2019
Q4
$691K Sell
3,377
-340
-9% -$62.3K 0.01% 221
2019
Q3
$564K Buy
3,717
+772
+26% +$126K 0.01% 257
2019
Q2
$464K Sell
2,945
-1,119
-28% -$175K 0.01% 293
2019
Q1
$654K Sell
4,064
-1,870
-32% -$342K 0.01% 211
2018
Q4
$1.13M Buy
5,934
+4,288
+261% +$895K 0.02% 142
2018
Q3
$343K Buy
1,646
+95
+6% +$17.6K 0.01% 363
2018
Q2
$264K Buy
+1,551
New +$268K 0.01% 412
2018
Q1
Sell
-118
Closed -$24K 559
2017
Q4
$24K Sell
118
-21
-15% -$4.18K ﹤0.01% 561
2017
Q3
$26K Buy
+139
New +$24.7K ﹤0.01% 526

Other funds holding CI

Greenleaf Trust's CI Position: Q2 2026 in Review

Greenleaf Trust reduced its Cigna (CI) stake by 0.81% in Q2 2026, selling an estimated $17.2K and leaving 7,480 shares worth $2.06M. The position accounts for 0.02% of the portfolio, ranked #214.

Greenleaf Trust first reported a position in CI in Q3 2017 and has held it in 35 quarters since. The position peaked at $3.65M in Q1 2024. 476 funds tracked by Wall St. Rank hold CI as of Q2 2026.

  • Greenleaf Trust held 7,480 shares of Cigna worth $2.06M as of Q2 2026.
  • Greenleaf Trust sold 61 Cigna shares in Q2 2026, an estimated $17.2K.
  • Cigna made up 0.02% of Greenleaf Trust's portfolio in Q2 2026, its #214 holding.
  • Greenleaf Trust first reported a position in Cigna in Q3 2017 and has held it in 35 quarters since.
  • Greenleaf Trust's Cigna position peaked at $3.65M in Q1 2024.
  • 476 funds tracked by Wall St. Rank held Cigna as of Q2 2026.

Based on Greenleaf Trust's 13F filing for Q2 2026, filed 21 Jul 2026.